X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (463) 463
Book Review (34) 34
Conference Proceeding (8) 8
Publication (8) 8
Patent (7) 7
Book Chapter (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (308) 308
humans (293) 293
female (283) 283
adult (183) 183
obstetrics & gynecology (108) 108
adolescent (98) 98
abridged index medicus (91) 91
middle aged (84) 84
women (80) 80
pregnancy (79) 79
risk factors (65) 65
human papillomavirus (62) 62
cervical cancer (53) 53
infectious diseases (51) 51
infection (49) 49
young adult (49) 49
health aspects (48) 48
papillomavirus infections - prevention & control (47) 47
male (42) 42
oncology (42) 42
cancer (41) 41
chlamydia trachomatis (41) 41
uterine cervical neoplasms - virology (41) 41
follow-up studies (40) 40
finland - epidemiology (39) 39
vaccination (39) 39
finland (38) 38
uterine cervical neoplasms - prevention & control (38) 38
papillomavirus infections (36) 36
infections (34) 34
prevalence (34) 34
diagnosis (31) 31
papillomavirus infections - virology (31) 31
risk (31) 31
vaccines (31) 31
young-women (31) 31
immunology (30) 30
medicine, general & internal (29) 29
prevention (29) 29
prospective studies (29) 29
aged (27) 27
case-control studies (27) 27
chlamydia trachomatis - isolation & purification (27) 27
research (27) 27
retrospective studies (26) 26
incidence (24) 24
medical and health sciences (24) 24
medicin och hälsovetenskap (24) 24
papillomavirus infections - epidemiology (24) 24
particle vaccine (24) 24
sexually transmitted diseases (24) 24
cohort studies (23) 23
papillomaviridae - immunology (23) 23
uterine cervical neoplasms - epidemiology (23) 23
double-blind method (22) 22
intraepithelial neoplasia (22) 22
papillomaviridae - genetics (22) 22
treatment outcome (22) 22
analysis (21) 21
cervical intraepithelial neoplasia - virology (21) 21
papillomaviruses (21) 21
animals (20) 20
care and treatment (20) 20
clinical trials (20) 20
efficacy (20) 20
hpv (20) 20
pregnancy outcome (20) 20
womens health (20) 20
cervical intraepithelial neoplasia (19) 19
chlamydia infections - epidemiology (19) 19
chlamydia trachomatis - immunology (19) 19
papillomaviridae - isolation & purification (19) 19
antibodies (18) 18
cervical intraepithelial neoplasia - prevention & control (18) 18
chlamydia infections - complications (18) 18
dna, viral - analysis (18) 18
follow-up (18) 18
human papillomavirus 16 - immunology (18) 18
human papillomavirus 18 - immunology (18) 18
hysterectomy (18) 18
immunization (18) 18
infant, newborn (18) 18
pelvic inflammatory disease (18) 18
registries (18) 18
chlamydia infections (17) 17
chlamydia infections - diagnosis (17) 17
papillomavirus infections - complications (17) 17
papillomavirus vaccines - administration & dosage (17) 17
papillomavirus vaccines - therapeutic use (17) 17
surgery (17) 17
vaginal smears (17) 17
biopsy (16) 16
chlamydia (16) 16
clinical medicine (16) 16
klinisk medicin (16) 16
management (16) 16
menorrhagia (16) 16
microbiology (16) 16
reproductive biology (16) 16
risk-factors (16) 16
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1989, ISBN 0306429659, xiv, 370 p., [2] p. of plates
Book
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 100 - 110
Summary Background We evaluated the efficacy of the human papillomavirus HPV-16/18 AS04-adjuvanted vaccine against non-vaccine oncogenic HPV types in the... 
Hematology, Oncology and Palliative Medicine | UNITED-STATES | AGED 16-26 YEARS | ONCOLOGY | PARTICLE VACCINE | NEOPLASIA | MAJOR CAPSID PROTEIN | YOUNG-WOMEN | CANCER | HUMAN-PAPILLOMAVIRUS INFECTION | LESIONS | EPITOPES | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adjuvants, Immunologic - administration & dosage | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Precancerous Conditions - diagnosis | Precancerous Conditions - virology | Time Factors | Adult | Female | Papillomavirus Infections - virology | Precancerous Conditions - pathology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Cervical Intraepithelial Neoplasia - virology | Cross Reactions | Antigens, Viral - immunology | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Precancerous Conditions - prevention & control | Australia | Human papillomavirus 16 - genetics | Prevention | Medical colleges | Analysis | Oncology, Experimental | Clinical trials | Cross infection | Vaccines | Nosocomial infections | Research | Papillomavirus infections | Cancer | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 89 - 99
Summary Background Cervical intraepithelial neoplasia grade 2 or greater (CIN2+) is the surrogate endpoint used in licensure trials of human papillomavirus... 
Hematology, Oncology and Palliative Medicine | COUNTRIES | ONCOLOGY | PARTICLE VACCINE | ADENOCARCINOMA | HPV VACCINATION | ADOLESCENT WOMEN | FOLLOW-UP | YOUNG-WOMEN | CANCER | CARCINOMA | HUMAN-PAPILLOMAVIRUS INFECTION | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adenocarcinoma - pathology | Adjuvants, Immunologic - administration & dosage | Age Factors | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Time Factors | Adult | Female | Papillomavirus Infections - virology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Adenocarcinoma - virology | Cervical Intraepithelial Neoplasia - virology | Adenocarcinoma - diagnosis | Adenocarcinoma - prevention & control | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Australia | Human papillomavirus 16 - genetics | Medical colleges | Care and treatment | Cervix dysplasia | Vaccination | Oncology, Experimental | Clinical trials | Vaccines | Research | Prevention | Sexually transmitted diseases | Analysis | Cross infection | Adults | Nosocomial infections | Children | Papillomavirus infections | Health aspects | Cervical cancer | Public health | Cancer | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9580, pp. 2161 - 2170
Journal Article
Annals of Medicine, ISSN 0785-3890, 02/2012, Volume 44, Issue 1, pp. 18 - 28
Journal Article
Human Vaccines, ISSN 1554-8600, 10/2009, Volume 5, Issue 10, pp. 696 - 704
Journal Article
BMJ, ISSN 0959-8138, 3/2012, Volume 344, Issue 7851, pp. 16 - 16
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 3/2010, Volume 102, Issue 5, pp. 325 - 339
Background The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital... 
AGED 16-26 YEARS | QUADRIVALENT VACCINE | ONCOLOGY | NEUTRALIZING EPITOPES | CLINICAL-TRIALS | DOUBLE-BLIND | TYPE-18 | VIRUS-LIKE PARTICLES | PROPHYLACTIC EFFICACY | RANDOMIZED CONTROLLED-TRIAL | CERVICAL INTRAEPITHELIAL NEOPLASIA | Human papillomavirus 18 - immunology | Human papillomavirus 6 - immunology | Tumor Virus Infections - virology | Humans | Uterine Cervical Neoplasms - epidemiology | Genital Diseases, Female - prevention & control | Sexually Transmitted Diseases - epidemiology | Alphapapillomavirus - immunology | Human papillomavirus 16 - immunology | Sexually Transmitted Diseases - prevention & control | Young Adult | Adult | Female | Papillomavirus Infections - virology | Cervical Intraepithelial Neoplasia - epidemiology | Human papillomavirus 11 - immunology | Tumor Virus Infections - epidemiology | Papillomavirus Vaccines - administration & dosage | Genital Diseases, Female - virology | Papillomavirus Infections - complications | Global Health | Papanicolaou Test | Sexually Transmitted Diseases - virology | Papillomavirus Infections - epidemiology | Kaplan-Meier Estimate | Uterine Cervical Neoplasms - prevention & control | Vaginal Smears | Papillomavirus Vaccines - pharmacology | Tumor Virus Infections - prevention & control | Cervical Intraepithelial Neoplasia - virology | Tumor Virus Infections - complications | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Sexual Partners | Prevention | Complications and side effects | Care and treatment | Young women | Research | Health aspects | Papillomavirus infections | Risk factors | Genital diseases, Female | Women | Studies | Human papillomavirus | Immunization | Teenagers | Vaccines | Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Acta Obstetricia et Gynecologica Scandinavica, ISSN 0001-6349, 2012, Volume 91, Issue 8, pp. 1002 - 1003
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9574, pp. 1693 - 1702
Journal Article
Acta Obstetricia et Gynecologica Scandinavica, ISSN 0001-6349, 10/2011, Volume 90, Issue 10, pp. 1140 - 1146
Objective. Placenta accreta is one of the most devastating pregnancy complications. We sought to compare outcomes between women with placenta accreta when... 
Placenta accreta | blood transfusion | antenatal diagnosis | outcome | peripartum blood loss | CONSERVATIVE TREATMENT | MANAGEMENT | ABNORMAL PLACENTATION | PREGNANCY | OBSTETRICS & GYNECOLOGY | Blood Loss, Surgical - prevention & control |